Utah Medical Products (UTMD) EBITDA Margin: History & Chart

Utah Medical Products, Inc.(UTMD)

Medical - Instruments & Supplies · Midvale, UT

$74.07+0.75 (+1.03%)

Delayed quote: Oct 6, 2026, 3:05 PM EDT

About Utah Medical Products, Inc.

Utah Medical Products, Inc. (UTMD) is a healthcare technology company focused on the creation, production, and supply of medical devices for the healthcare sector. UTMD offers a comprehensive portfolio of medical devices primarily serving labor and delivery departments and neonatal intensive care units. Key offerings include fetal monitoring accessories, vacuum-assisted delivery systems, and other specialized tools for childbirth. For newborns, they provide respiratory hoods (DISPOSA-HOOD), umbilical vessel catheters (GESCO), silicone oral protection devices (PALA-NATE), and lumbar sampling kits (MYELO-NATE). Beyond maternity care, the company supplies blood pressure monitoring systems (DELTRAN PLUS), disposable peritoneal dialysis sets (DIALY-NATE), urinary drainage systems (URI-CATH), and feeding devices (NUTRI-CATH/NUTRI-LOK). They also manufacture HEMO-NATE disposable filters, various catheterization procedure trays, and DELTRAN disposable pressure transducers along with related accessories and molded parts. A substantial portion of UTMD's offerings targets women's health and gynecological interventions. This includes advanced electrosurgical solutions like the LETZ system for cervical lesion excision, paired with FINESSE+ generators and various specialized electrodes (loop, ball, needle), and FILTRESSE evacuators. They also provide laparoscopic instruments (Femcare line), including trocars and cannulae, alongside EPITOME and OptiMicro electrosurgical devices. Complementing these are products for surgical contraception (Filshie Clip), endoscopic irrigation (PATHFINDER PLUS), suprapubic catheterization, and urinary incontinence management (LIBERTY systems). Specialized tools for uterine assessment and sampling, such as the ENDOCURETTE and TVUS/HSG-Cath, as well as the LUMIN uterine manipulator for laparoscopic procedures, complete this extensive portfolio. UTMD's diverse product range serves various healthcare settings, including neonatal intensive care units, labor and delivery wards, women's health centers within hospitals, outpatient clinics, and physicians' offices. The company facilitates distribution through a combination of direct customer service and sales teams, independent consultants, and manufacturer representatives. Established in 1978, Utah Medical Products, Inc. maintains its headquarters in Midvale, Utah.

Midvale, UT

146 employees

www.utahmed.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Kevin L. Cornwell

View full financials

UTMD EBITDA Margin Metrics

EBITDA MARGIN

37.26%

EBITDA MARGIN AVG TTM

36.04%

EBITDA MARGIN AVG 3Y

38.28%

EBITDA MARGIN AVG 5Y

44.36%

EBITDA MARGIN AVG 10Y

47.58%

EBITDA MARGIN AVG 15Y

46.73%

EBITDA MARGIN AVG 20Y

44.81%

CURRENT VS TTM AVG

+3.37%

CURRENT VS 3Y AVG

-2.65%

CURRENT VS 5Y AVG

-16.01%

CURRENT VS 10Y AVG

-21.69%

CURRENT VS 15Y AVG

-20.26%

CURRENT VS 20Y AVG

-16.85%

NAME	MARKET CAP	EBITDA MARGIN	TTM	3Y	5Y
Utah Medical Products, Inc. (UTMD)	$235.83M	37.26%	36.04%	38.28%	44.36%
Akebia Therapeutics, Inc. (AKBA)vs ›	$236.36M	10.49%	1.20%	-4.19%	-40.04%
CAMP4 Therapeutics Corporation (CAMP)vs ›	$236.58M	-1441.45%	-4661.83%	-5918.79%	-3944.51%
Invivyd, Inc. (IVVD)vs ›	$236.83M	-100.05%	-392.29%	-392.29%	-392.29%
InflaRx N.V. (IFRX)vs ›	$234.20M	-163095.33%	-97357.05%	-88166.59%	-88166.59%
Greenwich LifeSciences, Inc. (GLSI)vs ›	$237.72M	N/A	N/A	N/A	N/A
High Tide Inc. (HITI)vs ›	$238.13M	1.66%	3.74%	-1.53%	0.81%
SIGA Technologies, Inc. (SIGA)vs ›	$232.74M	25.65%	38.25%	43.91%	51.79%
Biodesix, Inc. (BDSX)vs ›	$231.18M	-25.05%	-32.88%	-63.97%	-61.52%
Lifecore Biomedical, Inc. (LFCR)vs ›	$242.12M	6.37%	-0.39%	-2.45%	1.13%

NAME

MARKET CAP

EBITDA MARGIN

TTM

Utah Medical Products, Inc. (UTMD)

$235.83M

37.26%

36.04%

38.28%

44.36%

Akebia Therapeutics, Inc. (AKBA)vs ›

$236.36M

10.49%

1.20%

-4.19%

-40.04%

CAMP4 Therapeutics Corporation (CAMP)vs ›

$236.58M

-1441.45%

-4661.83%

-5918.79%

-3944.51%

Invivyd, Inc. (IVVD)vs ›

$236.83M

-100.05%

-392.29%

InflaRx N.V. (IFRX)vs ›

$234.20M

-163095.33%

-97357.05%

-88166.59%

Greenwich LifeSciences, Inc. (GLSI)vs ›

$237.72M

N/A

High Tide Inc. (HITI)vs ›

$238.13M

1.66%

3.74%

-1.53%

0.81%

SIGA Technologies, Inc. (SIGA)vs ›

$232.74M

25.65%

38.25%

43.91%

51.79%

Biodesix, Inc. (BDSX)vs ›

$231.18M

-25.05%

-32.88%

-63.97%

-61.52%

Lifecore Biomedical, Inc. (LFCR)vs ›

$242.12M

6.37%

-0.39%

-2.45%

1.13%

EBITDA Margin FAQ

What is the EBITDA margin for Utah Medical Products, Inc. (UTMD)?

The EBITDA margin for UTMD stock is 37.26%.

Is Utah Medical Products, Inc.'s EBITDA margin high or low?

The EBITDA margin of 37.26% is 16% below its 5-year average of 44.36%, near the low end of its 5-year range (33.80%–55.11%).

What is the TTM average EBITDA margin for Utah Medical Products, Inc. (UTMD)?

The TTM average EBITDA margin for UTMD stock is 36.04%.

What is the 3Y average EBITDA margin for Utah Medical Products, Inc. (UTMD)?

The 3Y average EBITDA margin for UTMD stock is 38.28%.

What is the 5Y average EBITDA margin for Utah Medical Products, Inc. (UTMD)?

The 5Y average EBITDA margin for UTMD stock is 44.36%.

What is the 10Y average EBITDA margin for Utah Medical Products, Inc. (UTMD)?

The 10Y average EBITDA margin for UTMD stock is 47.58%.

What is the 15Y average EBITDA margin for Utah Medical Products, Inc. (UTMD)?

The 15Y average EBITDA margin for UTMD stock is 46.73%.

What is the 20Y average EBITDA margin for Utah Medical Products, Inc. (UTMD)?

The 20Y average EBITDA margin for UTMD stock is 44.81%.

DATE	EBITDA MARGIN
2026-06-30	33.80%
2026-03-31	37.30%
2025-12-31	35.24%
2025-09-30	34.28%
2025-06-30	39.60%
2025-03-31	39.90%
2024-12-31	39.82%
2024-09-30	40.81%
2024-06-30	39.72%
2024-03-31	40.26%
2023-12-31	40.30%
2023-09-30	46.01%
2023-06-30	48.22%
2023-03-31	49.54%
2022-12-31	50.15%
2022-09-30	53.15%
2022-06-30	50.89%
2022-03-31	51.38%
2021-12-31	53.68%
2021-09-30	55.11%
2021-06-30	52.44%
2021-03-31	52.22%
2020-12-31	50.62%
2020-09-30	51.44%
2020-06-30	42.78%
2020-03-31	52.07%
2019-12-31	54.81%
2019-09-30	49.32%
2019-06-30	53.16%
2019-03-31	51.83%
2018-12-31	51.10%
2018-09-30	49.27%
2018-06-30	52.98%
2018-03-31	52.73%
2017-12-31	51.85%
2017-09-30	53.09%
2017-06-30	52.83%
2017-03-31	52.63%
2016-12-31	48.44%
2016-09-30	47.93%
2016-06-30	48.15%
2016-03-31	49.05%
2015-12-31	47.94%
2015-09-30	48.26%
2015-06-30	45.71%
2015-03-31	45.46%
2014-12-31	49.92%
2014-09-30	45.28%
2014-06-30	46.81%
2014-03-31	47.63%
2013-12-31	43.45%
2013-09-30	44.42%
2013-06-30	45.01%
2013-03-31	45.14%
2012-12-31	44.58%
2012-09-30	45.50%
2012-06-30	43.60%
2012-03-31	44.04%
2011-12-31	37.61%
2011-09-30	40.60%
2011-06-30	39.40%
2011-03-31	35.67%
2010-12-31	37.67%
2010-09-30	38.82%
2010-06-30	37.33%
2010-03-31	37.91%
2009-12-31	38.99%
2009-09-30	37.91%
2009-06-30	37.38%
2009-03-31	40.37%
2008-12-31	35.70%
2008-09-30	43.03%
2008-06-30	40.03%
2008-03-31	39.00%
2007-12-31	39.32%
2007-09-30	40.33%
2007-06-30	39.76%
2007-03-31	39.93%
2006-12-31	39.43%
2006-09-30	41.39%
2006-06-30	39.53%
2006-03-31	39.25%
2005-12-31	33.35%
2005-09-30	31.47%
2005-06-30	37.59%
2005-03-31	41.04%
2004-12-31	38.97%
2004-09-30	41.20%
2004-06-30	41.42%
2004-03-31	43.21%
2003-12-31	42.62%
2003-09-30	43.43%
2003-06-30	43.29%
2003-03-31	43.20%
2002-12-31	42.50%
2002-09-30	43.61%

DATE

EBITDA MARGIN

2026-06-30

33.80%

2026-03-31

37.30%

2025-12-31

35.24%

2025-09-30

34.28%

2025-06-30

39.60%

2025-03-31

39.90%

2024-12-31

39.82%

2024-09-30

40.81%

2024-06-30

39.72%

2024-03-31

40.26%

2023-12-31

40.30%

2023-09-30

46.01%

2023-06-30

48.22%

2023-03-31

49.54%

2022-12-31

50.15%

2022-09-30

53.15%

2022-06-30

50.89%

2022-03-31

51.38%

2021-12-31

53.68%

2021-09-30

55.11%

2021-06-30

52.44%

2021-03-31

52.22%

2020-12-31

50.62%

2020-09-30

51.44%

2020-06-30

42.78%

2020-03-31

52.07%

2019-12-31

54.81%

2019-09-30

49.32%

2019-06-30

53.16%

2019-03-31

51.83%

2018-12-31

51.10%

2018-09-30

49.27%

2018-06-30

52.98%

2018-03-31

52.73%

2017-12-31

51.85%

2017-09-30

53.09%

2017-06-30

52.83%

2017-03-31

52.63%

2016-12-31

48.44%

2016-09-30

47.93%

2016-06-30

48.15%

2016-03-31

49.05%

2015-12-31

47.94%

2015-09-30

48.26%

2015-06-30

45.71%

2015-03-31

45.46%

2014-12-31

49.92%

2014-09-30

45.28%

2014-06-30

46.81%

2014-03-31

47.63%

2013-12-31

43.45%

2013-09-30

44.42%

2013-06-30

45.01%

2013-03-31

45.14%

2012-12-31

44.58%

2012-09-30

45.50%

2012-06-30

43.60%

2012-03-31

44.04%

2011-12-31

37.61%

2011-09-30

40.60%

2011-06-30

39.40%

2011-03-31

35.67%

2010-12-31

37.67%

2010-09-30

38.82%

2010-06-30

37.33%

2010-03-31

37.91%

2009-12-31

38.99%

2009-09-30

37.91%

2009-06-30

37.38%

2009-03-31

40.37%

2008-12-31

35.70%

2008-09-30

43.03%

2008-06-30

40.03%

2008-03-31

39.00%

2007-12-31

39.32%

2007-09-30

40.33%

2007-06-30

39.76%

2007-03-31

39.93%

2006-12-31

39.43%

2006-09-30

41.39%

2006-06-30

39.53%

2006-03-31

39.25%

2005-12-31

33.35%

2005-09-30

31.47%

2005-06-30

37.59%

2005-03-31

41.04%

2004-12-31

38.97%

2004-09-30

41.20%

2004-06-30

41.42%

2004-03-31

43.21%

2003-12-31

42.62%

2003-09-30

43.43%

2003-06-30

43.29%

2003-03-31

43.20%

2002-12-31

42.50%

2002-09-30

43.61%

EBITDA Margin: 37.26%

UTMD EBITDA Margin

UTMD Average EBITDA Margin Chart

UTMD Current vs Average EBITDA Margin Chart

UTMD EBITDA Margin Metrics

UTMD Competitors' EBITDA Margin

Margin Comparison

EBITDA Margin Formula & Definition

EBITDA Margin FAQ

UTMD EBITDA Margin History

Related Metrics